Patent ID: 11904081
Assignee: LUPAGEN, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 14:
15. A method of introducing a modification to a target nucleated blood cell, the method comprising:
parenterally connecting a subject in need of such modification to the system of claim 1, via the inlet and outlet conduits;
permitting the blood of the subject to flow into the cell separation module and producing a fraction enriched in a target nucleated blood cell type;
permitting a blood cell fraction enriched in the target cell type to flow from the cell separation module to the cell customization module and contacting the blood cell fraction enriched in the target cell type with one or more modifying agents, thereby generating modified cells; and
permitting the modified cells to parenterally flow to the subject via the outlet conduit.